Is there a relationship between mean blood glucose and glycated hemoglobin?

Konstantinos Makris1, Loukia Spanou

  • 1Clinical Biochemistry Department, KAT General Hospital, Athens, Greece. knmakris@hol.gr

Insights

Hemoglobin A1c (HbA1c) monitoring is key for diabetes, but patients struggle to understand it. This review confirms HbA1c closely relates to mean blood glucose (MBG), supporting translation for better patient comprehension.

Area of Science:

  • Endocrinology
  • Clinical Chemistry
  • Diabetes Management

Background:

  • Hemoglobin A1c (HbA1c) is the gold standard for monitoring diabetes, reflecting average blood glucose over 3 months.
  • HbA1c correlates with long-term complication risks but doesn't provide daily glucose insights.
  • Patients often lack understanding of HbA1c, hindering effective diabetes self-management.

Purpose of the Study:

  • To review scientific literature for evidence supporting a strong link between HbA1c and mean blood glucose (MBG).
  • To justify translating HbA1c values into a more patient-understandable MBG equivalent.
  • To assess the feasibility of a universal equation for HbA1c to MBG conversion.

Main Methods:

  • Systematic literature review of studies correlating HbA1c and MBG.
  • Analysis of reported linear equations and their variability.
  • Identification of factors influencing the HbA1c-MBG relationship.

Main Results:

  • The literature confirms a close relationship between HbA1c and MBG.
  • Multiple studies demonstrate this correlation, but with varying linear equations.
  • Factors influencing the relationship limit the applicability of a single conversion formula.

Conclusions:

  • HbA1c and MBG are closely related, supporting the concept of translating HbA1c for patient understanding.
  • The variability in conversion equations suggests a personalized approach may be necessary.
  • Further research is needed to refine HbA1c to MBG translation methods for diverse patient populations.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...